These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34928457)

  • 1. The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis.
    Mathijssen H; Tjoeng TWH; Keijsers RGM; Bakker ALM; Akdim F; van Es HW; van Beek FT; Veltkamp MV; Grutters JC; Post MC
    EJNMMI Res; 2021 Dec; 11(1):129. PubMed ID: 34928457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.
    Vita T; Okada DR; Veillet-Chowdhury M; Bravo PE; Mullins E; Hulten E; Agrawal M; Madan R; Taqueti VR; Steigner M; Skali H; Kwong RY; Stewart GC; Dorbala S; Di Carli MF; Blankstein R
    Circ Cardiovasc Imaging; 2018 Jan; 11(1):e007030. PubMed ID: 29335272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of cardiac sarcoidosis despite negative findings on serial late gadolinium enhancement with cardiac magnetic resonance imaging/
    Tanaka TD; Nagai T; Nagoshi T; Yoshimura M
    J Nucl Cardiol; 2020 Dec; 27(6):2149-2153. PubMed ID: 31773564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between significant fibrosis and active inflammation in patients with cardiac sarcoidosis: combined and image fusion analysis of cardiac magnetic resonance and
    Fukushima K; Nagao M; Yamamoto A; Serizawa N; Ishizaki U; Suzuki A; Sakai A; Watanabe E; Momose M; Kuji I; Abe K
    Eur J Hybrid Imaging; 2019 Jun; 3(1):9. PubMed ID: 34191189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Hatipoglu S; Gardezi SKM; Azzu A; Baksi J; Alpendurada F; Izgi C; Khattar R; Kouranos V; Wells AU; Sharma R; Wechalekar K; Pennell DJ; Mohiaddin R
    Heart; 2023 Apr; 109(10):748-755. PubMed ID: 36627181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
    Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
    Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
    Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.
    Bravo PE; Raghu G; Rosenthal DG; Elman S; Petek BJ; Soine LA; Maki JH; Branch KR; Masri SC; Patton KK; Caldwell JH; Krieger EV
    Int J Cardiol; 2017 Aug; 241():457-462. PubMed ID: 28318664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is positron emission tomography enough to rule out cardiac sarcoidosis? A case report.
    Huang S; Kunchakarra S; Rathod A
    Eur Heart J Case Rep; 2021 Sep; 5(9):ytab300. PubMed ID: 34557632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of
    Kaushik P; Patel C; Gulati GS; Seth S; Parakh N; Randeep Guleria ; Kumar R; Gupta P; Bal C
    Ann Nucl Med; 2021 Sep; 35(9):1058-1065. PubMed ID: 34125376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Borges-Rosa J; Oliveira-Santos M; Silva R; Gomes A; de Almeida J; Costa G; Gonçalves L; Ferreira MJ
    Int J Cardiol; 2022 Jan; 347():38-43. PubMed ID: 34736982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the latest advances in
    Miratashi Yazdi SN; Riahi F; Azizollahi S; Tooyserkani SH; Fesharaki S; Alaei M; Ghazanfari Hashemi M; Vakili Zarch M; Mojahedi A
    Am J Nucl Med Mol Imaging; 2024; 14(2):149-156. PubMed ID: 38737647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current uses and understanding of PET imaging in cardiac sarcoidosis.
    Madiraju A; Bhattaru A; Pham T; Pundyavana A; Rojulpote KV; Raynor WY; Werner TJ; Alavi A
    Am J Nucl Med Mol Imaging; 2024; 14(3):161-174. PubMed ID: 39027647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
    Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging in Suspected Cardiac Sarcoidosis: A Diagnostic Challenge.
    Ha FJ; Agarwal S; Tweed K; Palmer SC; Adams HS; Thillai M; Williams L
    Curr Cardiol Rev; 2020; 16(2):90-97. PubMed ID: 31345153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging.
    Elwazir MY; Bird JG; AbouEzzeddine OF; Chareonthaitawee P; Blauwet LA; Collins JD; Gibbons RJ; Rodriguez-Porcel M; Kamal HM; Abdellah AT; Bois JP
    J Nucl Cardiol; 2022 Jun; 29(3):1389-1401. PubMed ID: 33474694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.